September 20, 2014 5:29 AM ET

Pharmaceuticals

Company Overview of Metastatin Pharmaceuticals, Inc.

Company Overview

Metastatin Pharmaceuticals, Inc. develops cytostatic and antimetastatic therapies for the management of cancer in the United States. Its therapies focus on controlling tumor progression and metastasis using molecularly targeted compounds. The company’s compound includes ‘Uteroglobin’ that inhibits cell growth, invasiveness, and angiogenesis. Metastatin Pharmaceuticals, Inc. is headquartered in Bethesda, Maryland. As of March 1, 2007, Metastatin Pharmaceuticals, Inc. is a subsidiary of Samaritan Pharmaceuticals Inc.

6701 Democracy Boulevard

Suite 300

Bethesda, MD 20817

United States

Phone:

301-517-9419

Fax:

301-517-9385

Key Executives for Metastatin Pharmaceuticals, Inc.

Chief Financial Officer
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Medros, Inc. United States
Predict, Inc. United States
Zen Enterprises, LLC United States
Leptos Biomedical, Inc. United States
Addrenex Pharmaceuticals, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Metastatin Pharmaceuticals, Inc., please visit www.metastatin.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.